Literature DB >> 16153840

Structure-activity relationship study of novel necroptosis inhibitors.

Xin Teng1, Alexei Degterev, Prakash Jagtap, Xuechao Xing, Sungwoon Choi, Régine Denu, Junying Yuan, Gregory D Cuny.   

Abstract

Necroptosis is a regulated caspase-independent cell death mechanism that results in morphological features resembling necrosis. It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-alpha. 5-(1H-Indol-3-ylmethyl)-2-thiohydantoins and 5-(1H-indol-3-ylmethyl)hydantoins were found to be potent necroptosis inhibitors (called necrostatins). A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity. The hydantoin ring was also quite sensitive to structural modifications. A representative member of this compound class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon intravenous administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153840     DOI: 10.1016/j.bmcl.2005.07.077

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  61 in total

Review 1.  Chemical genetic approaches to probing cell death.

Authors:  Nidhi M Gangadhar; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2006-12-14       Impact factor: 8.822

Review 2.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Authors:  Tom Vanden Berghe; Andreas Linkermann; Sandrine Jouan-Lanhouet; Henning Walczak; Peter Vandenabeele
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

Review 3.  Cell death controlling complexes and their potential therapeutic role.

Authors:  Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

4.  Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation.

Authors:  Qiwei Wang; Zhenjie Liu; Jun Ren; Stephanie Morgan; Carmel Assa; Bo Liu
Journal:  Circ Res       Date:  2015-01-06       Impact factor: 17.367

5.  Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase.

Authors:  A Degterev; J L Maki; J Yuan
Journal:  Cell Death Differ       Date:  2012-11-30       Impact factor: 15.828

Review 6.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

7.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

8.  Expression and purification of active receptor interacting protein 1 kinase using a baculovirus system.

Authors:  Jenny L Maki; J Tres Brazell; Xin Teng; Gregory D Cuny; Alexei Degterev
Journal:  Protein Expr Purif       Date:  2013-03-21       Impact factor: 1.650

Review 9.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

Review 10.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.